282 related articles for article (PubMed ID: 23902297)
1. Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.
Hui L; Hyett J
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):416-24. PubMed ID: 23902297
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012.
Mersy E; Smits LJ; van Winden LA; de Die-Smulders CE; ; Paulussen AD; Macville MV; Coumans AB; Frints SG
Hum Reprod Update; 2013; 19(4):318-29. PubMed ID: 23396607
[TBL] [Abstract][Full Text] [Related]
4. An update on current prenatal testing options: first trimester and noninvasive prenatal testing.
Latendresse G; Deneris A
J Midwifery Womens Health; 2015; 60(1):24-36; quiz 111. PubMed ID: 25712277
[TBL] [Abstract][Full Text] [Related]
5. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
Maxwell S; Dickinson JE; Murch A; O'Leary P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M
Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population.
Fairbrother G; Johnson S; Musci TJ; Song K
Prenat Diagn; 2013 Jun; 33(6):580-3. PubMed ID: 23494956
[TBL] [Abstract][Full Text] [Related]
8. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Shaw SW; Chen CP; Cheng PJ
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing.
Maxwell S; O'Leary P; Dickinson JE; Suthers GK
Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):432-439. PubMed ID: 28369759
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of trisomy 21: a simple blood test?].
Salomon LJ
Gynecol Obstet Fertil; 2013 Feb; 41(2):77-9. PubMed ID: 23375986
[No Abstract] [Full Text] [Related]
11. [Maternal biochemical screening -- an approach for genetic prevention. part 1. first and second trimester screening].
Angelova L; Gadancheva V; Konstantinova D; Stoianova M; Hachmerian M; Yakov B; Kremenski I
Akush Ginekol (Sofiia); 2013; 52(5):8-13. PubMed ID: 24501862
[TBL] [Abstract][Full Text] [Related]
12. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
13. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
[TBL] [Abstract][Full Text] [Related]
14. First trimester Down syndrome screening: public health implications.
Fuchs KM; Peipert JF
Semin Perinatol; 2005 Aug; 29(4):267-71. PubMed ID: 16104680
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive prenatal testing for fetal trisomy in a mixed risk factors pregnancy population.
Li WH; Wang PH; Chuang CM; Chang YW; Yang MJ; Chen CY; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):122-5. PubMed ID: 25951714
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive prenatal testing: more caution in counseling is needed in high risk pregnancies with ultrasound abnormalities.
Oneda B; Steindl K; Masood R; Reshetnikova I; Krejci P; Baldinger R; Reissmann R; Taralczak M; Guetg A; Wisser J; Fauchère JC; Rauch A
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():72-5. PubMed ID: 26989803
[TBL] [Abstract][Full Text] [Related]
17. Prenatal screening for trisomy 21: recent advances and guidelines.
Canick J
Clin Chem Lab Med; 2012 Jun; 50(6):1003-8. PubMed ID: 21790505
[TBL] [Abstract][Full Text] [Related]
18. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
Tercanli S; Vial Y; Merz E
Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
[No Abstract] [Full Text] [Related]
20. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
Biggio JR; Morris TC; Owen J; Stringer JS
Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
